找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Delivery and Targeting; Monika Sch?fer-Korting,Ulrich S. Schubert Book 2024 The Editor(s) (if applicable) and The Author(s), under ex

[復(fù)制鏈接]
樓主: firearm
41#
發(fā)表于 2025-3-28 17:09:19 | 只看該作者
42#
發(fā)表于 2025-3-28 19:38:53 | 只看該作者
Nanomedicine – Immune System Interactions: Limitations and Opportunities for the Treatment of Cancerd opportunities of immune cell targeting with nanoparticles, and we discuss how nanoparticle-based drug delivery to specific immune cell populations in tumors as well as in secondary myeloid and lymphoid organs (such as bone marrow, lymph nodes, and spleen) can be leveraged to boost the efficacy of cancer immunotherapy.
43#
發(fā)表于 2025-3-29 02:37:45 | 只看該作者
Targeted Molecular Therapeutics for Pulmonary Diseases: Addressing the Need for Precise Drug Delivereting approaches, with a particular emphasis on nanoparticles, comparing targeted and non-targeted formulations for pulmonary administration. Finally, the potential of inhaled sphingolipids in the context of respiratory diseases is briefly discussed, highlighting their promising prospects in the field.
44#
發(fā)表于 2025-3-29 04:05:01 | 只看該作者
45#
發(fā)表于 2025-3-29 10:35:06 | 只看該作者
46#
發(fā)表于 2025-3-29 15:01:58 | 只看該作者
Anwendung der Verhaltensmedizincochemical solvent characteristics like water miscibility, viscosity, and vapor pressure for the selection of the formulation process, and for particle characteristics. New alternative solvents will be introduced for PLGA nanoparticle formation and compared regarding particle characteristics and bio
47#
發(fā)表于 2025-3-29 19:02:06 | 只看該作者
48#
發(fā)表于 2025-3-29 19:59:53 | 只看該作者
49#
發(fā)表于 2025-3-30 01:37:01 | 只看該作者
Property Directed Abstract Interpretationhat delivers nucleic acids including RNA to mitochondria is required, but efforts in this area have been limited compared to research targeting the nucleus and cytoplasm. This contribution provides an overview of mitochondria-targeted gene therapy strategies and discusses studies that have attempted
50#
發(fā)表于 2025-3-30 07:08:00 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-21 23:01
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
山丹县| 鱼台县| 临城县| 浙江省| 镇沅| 汉川市| 盐源县| 溧阳市| 光泽县| 峨眉山市| 济宁市| 朝阳县| 涿州市| 兴文县| 安吉县| 唐山市| 开阳县| 永昌县| 乌鲁木齐县| 海门市| 密山市| 额敏县| 安宁市| 隆化县| 印江| 上饶市| 大港区| 潢川县| 黄龙县| 奉化市| 博兴县| 康定县| 镇安县| 将乐县| 昆明市| 百色市| 揭阳市| 比如县| 夏河县| 巫山县| 河池市|